Chinese COVID vaccine developer Clover raised $240 million net proceeds in Hong Kong IPO
BEIJING (Reuters) – Chinese COVID-19 vaccine developer Clover Biopharmaceuticals said on Thursday it raised $240 million in net proceeds in […]
» Read more